,使

Suwan Hu1, Mengting Wang2

  • 1Department of Obstetrics and Gynecology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.

Discover oncology
|April 10, 2025
PubMed
概括

脱基因 (DUB) 基因影响卵巢癌的进展和免疫相互作用. 一种与DUB相关的新型风险特征 (DRS) 有效地对患者进行分层,有助于为这种侵袭性癌症制定个性化治疗策略.